# Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)

> **NCT03821376** · PHASE4 · TERMINATED · sponsor: **Indiana University** · enrollment: 12 (actual)

## Conditions studied

- Renal Malignant Tumor

## Interventions

- **DRUG:** Contrast enhanced ultrasound with Lumason

## Key facts

- **NCT ID:** NCT03821376
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-16
- **Primary completion:** 2021-09-21
- **Final completion:** 2021-09-21
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study stopped due to staffing issues that impacted ability to recruit.
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03821376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03821376, "Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03821376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*